Long-term safety and effectiveness of mepolizumab for patients with bronchial asthma in routine clinical practice in Japan — final report of special drug use investigation
This analysis of real-world data demonstrates that mepolizumab was well tolerated and effective in patients with bronchial asthma in Japan.
Authors
- Masaki Komatsubara
- E Tsuboi (ORCID: https://orcid.org/0009-0007-5131-6928)
- Peter Howarth (ORCID: https://orcid.org/0000-0003-0619-7927)
- Katsuo Aizawa
- Hironori Aoki
Institutions
- Veterans Health Administration (US)
- GlaxoSmithKline (Japan) (JP)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Geotechnical Consulting Group (United Kingdom) (GB)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1016/j.resinv.2025.05.003
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- GlaxoSmithKline